Focus: Cancer Center Featured Story 2

• share
• favorite_border

A new study of California firearm data identifies specific risk factors associated with a legally purchased gun that is later used in a crime.

• share
• favorite_border

Rutgers Cancer Institute of New Jersey and RWJBarnabas Health have appointed Nirag Jhala, MD, as chief of the Division of Oncologic Pathology at New Jersey’s leading cancer program and only National Cancer Institute (NCI)-designated Comprehensive Cancer Center.

• share
• favorite_border

MD Anderson's Institute for Data Science in Oncology today announced the appointment of its inaugural cohort of 33 IDSO Affiliates, who bring diverse expertise to advance the work of the institute and foster the data science ecosystem at MD Anderson.

• share
• favorite_border

Infectious diseases specialists call the medical field to be ready to deal with the impact of climate change on spreading diseases, such as malaria, Valley fever, E-coli and Lyme disease.

• share
• favorite_border

The UNM Comprehensive Center is expanding a program aimed at encouraging young people to explore research as a career field. In addition to a first-ever middle school component, the program is adding more opportunities for high school and undergraduates to get real world lab and research experience.

• share
• favorite_border

The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research and prevention.

• share
• favorite_border

Taneal D. Carter, MS, MPA, Manager of Cancer Care Equity Program for NCCN, has been named one of 2024’s ‘40 Under 40’ by the National Minority Quality Forum (NMQF). Visit NCCN.org/equity for more information.

• share
• favorite_border

UC Davis health researchers evaluated California’s mental health crisis management and prevention programs. Their report identified gaps in the system and called for more sustainable programs and community collaborations to support people with mental illness.

• share
• favorite_border

A team at Memorial Sloan Kettering Cancer Center (MSK) led by thoracic surgeon Prasad Adusumilli, MD, has been awarded a distinguished UG3/UH3 grant from the National Cancer Institute (NCI) to advance research and testing of chimeric antigen receptor (CAR) T cell therapy for solid tumors.

• share
• favorite_border

Dana-Farber Cancer Institute launched the Neuro-Inclusive Oncology Care and Empowerment Program, a psychosocial oncology program that is specialized for adults with intellectual and/or developmental disabilities (IDD).

• share
• favorite_border

Yale Cancer Center (YCC) and Smilow Cancer Hospital physicians and scientists will share new data for breakthrough and emerging cancer treatments as well as new discoveries in obesity, tobacco, evolution, and early onset cancers in early April at the American Association for Cancer Research (AACR) annual meeting.

• share
• favorite_border

Students who use both tobacco and cannabis (marijuana) have lower grades and miss more school than students who only use one product or don’t use either. Tobacco consumption among high school students, including vaping and e-cigarettes, is a concerning 12.6%.

• share
• favorite_border

Scott Armstrong, MD, PhD, has been named senior vice president for drug discovery and chief research strategy officer at Dana-Farber Cancer Institute. In this new role, he will lead Dana-Farber's institutional research strategy with an initial focus on therapeutic discovery work.

• share
• favorite_border

A blood test intended for screening for colorectal cancer in people who are of average risk and not experiencing symptoms correctly detected colorectal cancer in 83% of people confirmed to have the disease, according to a study published March 14 in the New England Journal of Medicine.

• share
• favorite_border

The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research and prevention. These advances are made possible through seamless collaboration between MD Anderson’s world-leading clinicians and scientists, bringing discoveries from the lab to the clinic and back.

• share
• favorite_border

Tengteng Wang, PhD, MSPH, MBBS, cancer epidemiologist in the Section of Cancer Epidemiology and Health Outcomes at Rutgers Cancer Institute of New Jersey, has received more than $700,000 from the National Cancer Institute (R00CA267557) to support her research on examining the association between reproductive factors, gut microbiome, and benign breast disease (BBD).

• share
• favorite_border

Our GI cancer specialists perform the newest and most effective practices for diagnosing and treating pre-cancerous and cancerous conditions involving the colon. Dr. Pat Gulhati breaks down colorectal cancer and the advancements at Rutgers Cancer Institute, New Jersey's only NCI-designated Comprehensive Cancer Center.

• share
• favorite_border

An international interdisciplinary team of researchers, including Moffitt Cancer Center’s Tiffany Carson, Ph.D., has been selected to receive a Cancer Grand Challenges award.

• share
• favorite_border

Alex Jaeger, Ph.D., assistant member of the Molecular Oncology Department at Moffitt Cancer Center, has received a Damon Runyon-Rachleff Innovation Award. He is the first researcher in Florida and at Moffitt to earn this prestigious grant.

• share
• favorite_border

The kidneys are two bean-shaped organs located just below the rib cage, one on each side of your spine. Healthy kidneys filter blood to remove waste and extra water to make urine. Kidney cancer, also known as renal cell carcinoma or RCC, forms when healthy cells in one or both kidneys grow out of control. Learn more with Dr. Saum Ghodoussipour from Rutgers Cancer Institute of New Jersey.

• share
• favorite_border

Below are summaries of recent Fred Hutchinson Cancer Center research findings and other news. March is Colorectal Cancer Awareness Month, contact our media team to set up interviews.

• share
• favorite_border

Rutgers Cancer Institute of New Jersey together with RWJBarnabas Health, the state’s leading cancer center and only Comprehensive Cancer Center as recognized by the National Cancer Institute (NCI), has scored in the “exceptional” range and was redesignated by the National Cancer Institute, placing it among the top cancer centers reviewed in 2023.

• share
• favorite_border

Florette K. Gray Hazard, a pediatric pathologist, has been appointed chair of the Department of Pathology and Laboratory Sciences at the UC Davis School of Medicine. She will lead a department with 50 faculty, 16 residents, and more than 400 academic and clinical staff.

• share
• favorite_border

Pool Cool is a program designed to educate young people in The University of Kansas Cancer Center’s catchment area on sun safety behaviors.

• share
• favorite_border

Recent NCCN Guidelines updates—along with the supporting evidence—will be presented during the NCCN 2024 Annual Conference held in Orlando, Florida April 5-7, and simultaneously online. Visit NCCN.org/conference to learn more and register.

• share
• favorite_border

SEATTLE — March 1, 2024 — Fred Hutchinson Cancer Center announced 12 recipients of the 2024 Harold M. Weintraub Graduate Student Award, which recognizes exceptional achievement in graduate studies in the biological sciences. This year’s recipients come from U.S. and international research institutions with thesis topics that include brain signals related to learning and emotion, bacterial pathogens and health, AI algorithms in rare disease diagnosis and treatment, and immune cells involved in brain tumors.

• share
• favorite_border

• share
• favorite_border

A team at UC Davis has developed a machine-learning model that can better predict which patients are at greater risk to develop hepatocellular carcinoma.

• share
• favorite_border

Howard S. Hochster, MD, FACP, director of the Gastrointestinal Oncology Program and Rutgers Cancer Institute of New Jersey Associate Director for Clinical Research and director of Oncology Research, RWJBarnabas Health shares his recommendations about keeping our attention focused on barriers to health care and preventive services and continuing to educate ourselves and others about colorectal cancer to reduce disparities.

• share
• favorite_border

Colorectal cancer (CRC) is on the rise in young adults. Incidences of colorectal cancer in young people (those between their mid-20s and late 50s) has more than doubled since the 1990s. Howard S. Hochster, MD, FACP, director of the Gastrointestinal Oncology Program and Rutgers Cancer Institute of New Jersey Associate Director for Clinical Research and director of Oncology Research, RWJBarnabas Health, shares his thoughts on this trend.

• share
• favorite_border

• share
• favorite_border

Researchers at The University of Texas MD Anderson Cancer Center built a new atlas of lung cells, uncovering new cellular pathways and precursors in the development of lung adenocarcinoma, the most common type of lung cancer. These findings, published today in Nature, open the door for development of new strategies to detect or intercept the disease in its earliest stages.

• share
• favorite_border

In the GENERATE study, 90% of those who viewed an online genetic education program chose to be tested for inherited predisposition to pancreatic cancer.

• share
• favorite_border

A preclinical study led by a team of researchers at Roswell Park Comprehensive Cancer Center highlights the potential of a novel two-drug treatment strategy targeting p53-mutant cancers.

• share
• favorite_border

In a mini-review published in Cancer Epidemiology, Biomarkers & Prevention, a journal from the American Association for Cancer Research, Moffitt Cancer Center researchers shed light on the significant gaps in understanding and addressing the effects of hurricanes and extreme weather events on biological, psychosocial and clinical outcomes among cancer survivors.

• share
• favorite_border

Dana-Farber Cancer Institute (Boston, MA, USA) and Gustave Roussy (Grand Paris, Villejuif, France) have announced that the third Transatlantic Exchange in Oncology Conference will address: Liquid Biopsy as an Emerging Approach in Precision Cancer Medicine.The meeting, supported by L’Institut Servier, will be held in-person (witha virtual attendance option) on April 12, 2024, at the Revere Hotel Boston Common and livestreamed virtually on Medscape’s platform.

• share
• favorite_border

MD Anderson has acquired certain assets from Bellicum Pharmaceuticals, Inc. related to the CaspaCIDE switch and GoCAR platforms. As a result, MD Anderson may incorporate these technologies into its own cell therapy programs as well as make them available for licensing to interested parties.

• share
• favorite_border

A researcher at The University of Kansas Cancer Center has received a $930,000 grant from the U.S. Department of Defense to study a new targeted therapy option for people diagnosed with ductal carcinoma in situ (DCIS).

• share
• favorite_border

The findings out of Dana-Farber Cancer Institute highlight that the mechanisms of immune modulation are different in patients treated with immunotherapy and anti-angiogenic combinations. The results also point to the role of tumor biology in the diversity and actions of tumor-infiltrating immune cells brought into action by these treatments. The findings might be important for predicting or understanding treatment outcomes in advanced kidney cancer.

• share
• favorite_border

Two new measurements have been added to the Health Equity Report Card (HERC)—a tool for improving the quality and equity of cancer care. This expansion is part of ongoing efforts to address the impact of structural and interpersonal racism as a cause of disparities in cancer outcomes in the United States.

• share
• favorite_border

The University of Texas MD Anderson Cancer Center today was awarded 16 grants totaling over $25.5 million from the Cancer Prevention and Research Institute of Texas (CPRIT) in support of cancer screening, early detection and prevention programs, faculty recruitment, and groundbreaking cancer research across all areas of the institution.

• share
• favorite_border

Could the TB vaccine be a new immunotherapy for liver cancer? A UC Davis Health study found that the century-old vaccine reduced tumors and extended survival for mice with liver cancer.

• share
• favorite_border

The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research and prevention. These advances are made possible through seamless collaboration between MD Anderson’s world-leading clinicians and scientists, bringing discoveries from the lab to the clinic and back. Recent developments at MD Anderson offer insights into drug-drug interactions for patients with acute myeloid leukemia (AML) and myelodysplastic syndromes; patient-derived xenograft models as a viable translational research tool in early-phase clinical trials; a novel gene expression signature to stratify patients with bladder cancer; a potential therapeutic target to overcome treatment resistance in multiple myeloma; a role for mutant p53 in protecting against ferroptosis in triple-negative breast cancer; and diet modifications to improve treatment outcomes in FLT3-mutated AML.

• share
• favorite_border

A first-of-its-kind cellular immunotherapy pioneered at Moffitt Cancer Center has received approval from the Food and Drug Administration and is now available for patients with advanced melanoma. Lifileucel is the first tumor-infiltrating lymphocyte therapy, or TIL, approved for solid tumors.

• share
• favorite_border

The Scarlet Knights presented a $50,000 check from the Kay Yow Cancer Fund to RWJBarnabas Health and Rutgers Cancer Institute of New Jersey to establish the Rutgers Women’s Basketball Cancer Support Game Plan, which will provide funding assistance for underserved female cancer patients across the State of New Jersey.

• share
• favorite_border

Prajakta Adsul, MBBS, PhD, MPH, from UNM Cancer Center attended the White House Cervical Cancer Forum focused on education, prevention, early detection and treatment. The Forum was held in late January.

• share
• favorite_border

In a new article published in the Journal of the National Cancer Institute, Moffitt Cancer Center researchers share data on the efficacy and safety of neoadjuvant chemotherapy for locally advanced penile squamous cell carcinoma, addressing a critical gap in evidence regarding treatment options for this rare and aggressive cancer.

• share
• favorite_border

Scientists at the UC Davis School of Medicine may have figured out why some people have trouble digesting sorbitol, a sugar alcohol used in sugar-free gum, mints, candy and other products.

• share
• favorite_border

• share
• favorite_border

A specific combination of targeted therapy and immunotherapy may better help patients with non-small cell lung cancer (NSCLC) overcome inherent immune resistance and reinvigorate anti-tumor activity, according to a new study led by a researcher from The University of Texas MD Anderson Cancer Center.